Open AccessI.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life
Author(s) -
Vicente Lorenzo-Zúñiga,
Elba Llop,
C Suárez,
Beatriz Álvarez,
L. Díaz Abreu,
Jordi Espadaler,
Jordi Serra
Publication year - 2014
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v20.i26.8709
Subject(s) - placebo , irritable bowel syndrome , medicine , diarrhea , quality of life (healthcare) , gastroenterology , adverse effect , probiotic , randomized controlled trial , clinical trial , pathology , alternative medicine , nursing , biology , bacteria , genetics
To determine the dose-related effects of a novel probiotic combination, I.31, on irritable bowel syndrome (IBS)-related quality of life (IBS-QoL).